Market Value2,304,694,420
Total Holdings76
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CTLT / Catalent, Inc.
JAZZ / Jazz Pharmaceuticals plc
/ ONCOLOGY INSTITUTE INC/THE
BMY / Bristol-Myers Squibb Company
IQV / IQVIA Holdings Inc.
TCRR / Tcr2 Therapeutics Inc
ALXO / ALX Oncology Holdings Inc.
DXCM / DexCom, Inc.
FATE / Fate Therapeutics, Inc.
ETNB / 89bio, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
RAPT / RAPT Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
NRIX / Nurix Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
RVMD / Revolution Medicines, Inc.
HOOK / HOOKIPA Pharma Inc.
IONS / Ionis Pharmaceuticals, Inc.
AKRO / Akero Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
ADCT / ADC Therapeutics SA
ARGX / argenx SE - Depositary Receipt (Common Stock)
BVS / Bioventus Inc.
SRPT / Sarepta Therapeutics, Inc.
RGNX / REGENXBIO Inc.
CLDX / Celldex Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
XENE / Xenon Pharmaceuticals Inc.
OSH / Oak Street Health Inc
IVVD / Invivyd, Inc.
ZYME / Zymeworks Inc.
CTSO / Cytosorbents Corporation
DCPH / Deciphera Pharmaceuticals, Inc.
TKNO / Alpha Teknova, Inc.
LSAQ / LifeSci Acquisition II Corp
MDVL / MedAvail Holdings, Inc.
SYK / Stryker Corporation
ISEE / IVERIC bio Inc
ELV / Elevance Health, Inc.
CNC / Centene Corporation
ONEM / 1life Healthcare Inc
VTYX / Ventyx Biosciences, Inc.
STTK / Shattuck Labs, Inc.
NUVB / Nuvation Bio Inc.
LVTX / LAVA Therapeutics N.V.
SRRK / Scholar Rock Holding Corporation
KRYS / Krystal Biotech, Inc.
FOLD / Amicus Therapeutics, Inc.
ILMN / Illumina, Inc.
SONX / Sonendo, Inc.
HUM / Humana Inc.
IMGN / ImmunoGen, Inc.
NLTX / Neoleukin Therapeutics, Inc.
SLGC / Standard BioTools Inc.
NVTA / Invitae Corporation
XERS / Xeris Biopharma Holdings, Inc.
ANNX / Annexon, Inc.
IGMS / IGM Biosciences, Inc.
BSX / Boston Scientific Corporation
PLRX / Pliant Therapeutics, Inc.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
CRL / Charles River Laboratories International, Inc.
STVN / Stevanato Group S.p.A.
ALVR / AlloVir, Inc.
TRDA / Entrada Therapeutics, Inc.
IMVT / Immunovant, Inc.
PEN / Penumbra, Inc.
LIVN / LivaNova PLC
STXS / Stereotaxis, Inc.
KYMR / Kymera Therapeutics, Inc.
BCEL / Atreca, Inc.
ATRA / Atara Biotherapeutics, Inc.
GRTSQ / Gritstone bio, Inc.
VERV / Verve Therapeutics, Inc.
PRME / Prime Medicine, Inc.
ABSI / Absci Corporation
REPL / Replimune Group, Inc.
AUGX / Augmedix, Inc.
ALLK / Allakos Inc.